SEC 13F Intelligence

Knott David M / TREUR

Knott David M’s Trillium Therapeutics Inc Position

Does Knott David M own Trillium Therapeutics Inc (TREUR)? Yes — 198.7K shares worth $3M (+1.27% of its 13F portfolio) as of Q3 2021.

Position Value
$3M
Q3 2021
Shares
198.7K
% of Portfolio
+1.27%
Quarters Held
7
currently held

Position History TREUR

Reported value by quarter
Q1 ’20: $551,000Q1 ’20Q2 ’20: $2MQ2 ’20Q3 ’20: $3MQ3 ’20Q4 ’20: $3MQ4 ’20Q1 ’21: $2MQ1 ’21Q2 ’21: $2MQ2 ’21Q3 ’21: $3MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021198.7K$3M+1.27%
Q2 2021198.7K$2M+0.68%
Q1 2021198.7K$2M+0.91%
Q4 2020174.7K$3M+1.16%
Q3 2020176.2K$3M+1.47%
Q2 2020264.2K$2M+1.17%
Q1 2020136.5K$551,000+0.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Knott David M’s full portfolio or all institutional holders of TREUR.